Teva to Discontinue Digital Inhalers
Teva Pharmaceuticals is discontinuing its series of digital inhalers starting June 1, 2024. Teva’s digital
Teva Pharmaceuticals is discontinuing its series of digital inhalers starting June 1, 2024. Teva’s digital
Drug companies Boehringer Ingelheim, AstraZeneca and GSK have announced they are capping out-of-pocket costs for
BCBSM Update BCBSM approves Flovent ABA for members less than 5 years of age. No
General Update Flovent HFA and Flovent Diskus are inhaled corticosteroid medicines used as a controller
INHALE prepares regular PO and Clinical level newsletters that contain:
Support for the INHALE CQI is provided by Blue Cross Blue Shield of Michigan as part of the BCBSM Value Partnerships program. BCBSM’s Value Partnerships program provides clinical and executive support for all CQI programs.
Although Blue Cross Blue Shield of Michigan and the INHALE CQI work in partnership, the opinions, beliefs, and viewpoints expressed by INHALE CQI do not necessarily reflect the opinions, beliefs, and viewpoints of BCBSM or any of its employees.